A detailed history of J. Safra Sarasin Holding Ag transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 25,500 shares of AUPH stock, worth $223,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,500
Previous 25,500 -0.0%
Holding current value
$223,635
Previous $146 Million 28.37%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$4.81 - $5.78 $122,654 - $147,390
25,500 New
25,500 $146 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.24B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.